Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Phio Pharmaceuticals Corp. (PHIO) had Normalized Income after Taxes of $-2.39M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.39M |
|
-- |
|
-- |
|
$2.50M |
|
$-2.50M |
|
$0.11M |
|
$-2.39M |
|
$-2.39M |
|
$-2.39M |
|
$-2.39M |
|
$-2.39M |
|
|
Normalized Income after Taxes |
$-2.39M |
$-2.50M |
|
$-2.50M |
|
5.47M |
|
5.47M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$11.49M |
|
$0.01M |
|
$0.01M |
|
$11.51M |
|
$1.67M |
|
-- |
|
-- |
|
$1.67M |
|
$9.84M |
|
$9.84M |
|
$9.84M |
|
5.79M |
|
| Cash Flow Statement Financials | |
$-5.90M |
|
$-0.01M |
|
$11.23M |
|
$5.38M |
|
$10.71M |
|
$5.32M |
|
$0.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.31% |
|
-24.31% |
|
-20.79% |
|
-24.31% |
|
$1.70 |
|
$-1.08 |
|
$-1.08 |
|